Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

Australian Cannabis Shares Get High on Government Exports

Shares of Cann Group Limited (ASX:CAN), Auscann Group Holdings Ltd (ASX:AC8), Creso Pharma Ltd (ASX:CPH), Stemcell United Ltd (ASX:SCU) and MMJ Phytotech Ltd (ASX:MMJ) have bounced on the Australian Government's export approval.

Shares of Cann Group Limited (ASX: CAN), Auscann Group Holdings Ltd (ASX: AC8), Creso Pharma Ltd (ASX: CPH), Stemcell United Ltd (ASX: SCU) and MMJ Phytotech Ltd (ASX: MMJ) have bounced higher today following the Australian Government’s export approval.

What happened?

Shares of Australia’s major publicly listed medical cannabis companies rallied on Thursday following a decision by the Australian Federal Government Minister Greg Hunt to approve the export of cannabis products overseas.

“We are making these changes because the expanding domestic medicinal cannabis products industry is facing increasing competition from imports,” Minister Hunt said.

The local industry appears to agree.

“…this decision will help ensure Australians benefit from a stronger, economically viable industry that is incentivised to develop world leading medicinal cannabis products to which they will have access,” Peter Crock, CEO of the $350 million Cann Group, said.

“The Federal Government is playing an important leadership role in helping to facilitate easier access for Australian patients and we now see an opportunity for those requirements to be further harmonised at a state level.”

Cann Group is currently developing a cultivation and manufacturing facility and has an agreement with the $6 billion Canadian company, Aurora Cannabis. It recently commissioned a facility north of Melbourne.

Pot Stocks Grow Like Weeds

Cannabis shares throughout the Western world have been a hot topic in recent years, with a push in states throughout the USA and Canada to legalise the drug.

Here in Australia, some commentators and medical experts have called to expedite access to the drug for patients suffering from certain diseases, some of which are terminal and significantly painful.

Minister Hunt said local patients will get priority access to locally produced products.

“It will be a condition of any licence authorising export that medicinal cannabis products be made available, when and if required, to Australian patients first,” Minister Hunt said.

Doctors can apply to become an authorised prescriber and legally distribute medicinal cannabis drugs to patients.

Join Our Free Investing Club Today

Looking to get the latest news and information on investing in Australia? You can join our investing network today by clicking here. It’s free to join.

Keep Reading:

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

Skip to content